ETANERCEPT TREATMENT RESULTS IN CHILDREN WITH NON-SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS: REMISSION, RECRUDESCENCE, AND ADVERSE EVENTS. RETROSPECTIVE COHORT STUDY

• Asıl Yazarlar: Mikhail M. Kostik (Yazar), Irina A. Chikova (Yazar), Eugenia A. Isupova (Yazar), Maria N. Likhacheva (Yazar), Tatyana S. Likhacheva (Yazar), Margaruta F. Dubko (Yazar), Vera V. Masalova (Yazar), Ludmila S. Snegireva (Yazar), Ekaterina V. Gaidar (Yazar), Olga V. Kalashnikova (Yazar), Vyacheslav G. Chasnyk (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: "Paediatrician" Publishers LLC, 2018-05-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Background. Etanercept is a biological drug most commonly used in patients with juvenile idiopathic arthritis (JIA). The results of its use are showed in local studies.Objective. Our aim was to evaluate the efficacy and safety of the use of etanercept in children with non-systemic JIA, to determine...